Medication info
Bialcandaplus Tablet

Bialcandaplus Tablet

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Boryung (Co., Ltd.)
Appearance
Biconvex light pink oblong tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200903842 · Notified 2009.05.29

Summary

Main use
Treatment of essential hypertension not controlled with single-ingredient therapy
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have reduced effective blood volume, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the candesartan cilexetil dose before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the candesartan cilexetil dose be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Boryung (Co., Ltd.)

Efficacy & effects

Treatment of essential hypertension not controlled with single-ingredient therapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose individual component therapy is insufficient. Proper blood pressure control is necessary to reduce the risk of cardiovascular complications, and this drug helps to lower blood pressure effectively through the combined action of various ingredients. Therefore, this medicine is used when blood pressure management is difficult to stabilize.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is generally achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have reduced effective blood volume, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the candesartan cilexetil dose before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the candesartan cilexetil dose be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This drug may cause serious harm to the fetus and newborn during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It is safe not to take this medication if you are allergic to any of the ingredients or sulfonamide drugs, are pregnant or planning to become pregnant, or are nursing. Patients with severe renal dysfunction or serious liver impairment, those with hereditary angioedema or a history of angioedema due to related medications should not use this drug. Patients with gout, hyponatremia, hypokalemia, hypercalcemia, or Addison's disease should also use this medication with caution, and specific renal disease or diabetic patients should pay attention to drug interactions with concomitant medications. Patients with fluid or electrolyte imbalances, liver disease, severe heart valve disease, elderly patients, etc., should use this drug carefully due to a higher risk of side effects such as blood pressure drop or kidney function deterioration. Since the hydrochlorothiazide component may increase the risk of skin cancer, it is advisable to avoid sun exposure and consult a doctor immediately if any skin abnormalities occur. During the administration of this drug, symptoms such as headache, dizziness, fatigue, indigestion, or signs of infection may occur, and regular testing is required as blood tests may reveal electrolyte imbalances or changes in kidney function. When used with other medications that may enhance the hypotensive effect or increase side effect risks, it is essential to consult healthcare professionals, especially regarding potassium-sparing diuretics, potassium supplements, NSAIDs, and lithium. Medication should be avoided during pregnancy or breastfeeding, and safety has not been established for children or adolescents under 18 years. In case of overdose, symptoms like hypotension, dizziness, electrolyte imbalance may occur, so immediate contact with a medical institution for appropriate treatment is necessary. This medication should be stored out of reach of children and kept in its original container to maintain its quality. Caution should be exercised when driving or operating machinery as dizziness or fatigue may occur.

Side effects

  • headache
  • back pain
  • dizziness
  • respiratory tract infection
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • bruising
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • rhinitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • increased urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dizziness
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • elevated liver enzymes
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • sensory disturbances
  • transient blurred vision
  • choroidal effusion
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • anorexia
  • loss of appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus erythematosus-like reaction
  • activation of lupus erythematosus
  • muscle spasms
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • otalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture and kept in a cool place below 30 degrees Celsius. Proper storage can maintain the effectiveness of the drug and prevent deterioration.

Appearance and packaging

Appearance

Biconvex light pink oblong tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.